PATENT CLAIM ANALYSIS

Application Number: 16109053
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "009400"]

Abstract:
Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.

Claim (Index 1):
A method of treating inflammation of the central nervous system (CNS) in a mammal in need thereof, comprising administering to the mammal a composition comprising one or more X-ray contrast media in an amount sufficient to treat said inflammation of the CNS, wherein a) the X-ray contrast media comprises a triiodinated, benzene moiety, b) the X-ray contrast media is a non-ionic monomer, non-ionic dimer, ionic monomer or ionic dimer, c) the composition is administered to a CNS tissue of the mammal by administering the composition into a nasal passage of the mammal, d) the mammal is a human, and e) the inflammation of the CNS is associated with a migraine or a headache.

Metadata:
- Claim Count in Document: 63.0
- Percentile: 96.0
- Lexical Diversity: 1.2
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13889124', '13888256', '15004775', '13865955', '11217578']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6995386543934492
- 35 USC 102 Novelty (BERT): 0.5753024217696543
- Combined Prediction Score: 0.6871150311310698
- Mean Citation Score: 310.872934
- Max Citation Score: 474.30368
- Similarity Product: 403.1271828891945

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test